$HBAN

TORGOW GARY purchased $200K of HBAN

TORGOW GARY purchased 12,700 shares of HUNTINGTON BANCSHARES INC /MD/ (HBAN) at $15.74 ($0.20M total) on 2026-10-27.

Original reporting
SEC EDGAR · TORGOW GARY
Published Oct 29, 2026, 8:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HBAN
Neutral
medium confidence
Mentioned
$HBAN
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HBANNeutralLow
01

Why it matters

The director's purchase adds a small amount of insider confidence but is unlikely to move the stock significantly.

02

Market read

A modest insider buy; low immediate trading relevance.

03

What to watch

Potential upcoming earnings or regulatory news could amplify the impact of this filing.

Relevance 5/10Novelty 5/10Timing: after market today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$HBANNeutralMedium confidence
Context

Director Gary Torgow purchased 12,700 shares of Huntington Bancshares for $199,834.50, increasing his holdings to 956,041 shares.

Expected impact

modest upward pressure as investors price in insider confidence

Evidence & confidence

The transaction size (~$200K) is modest for a mid‑cap bank, so any price move is likely limited.

Market effects

Minimal effect on regional banking sector; insider activity is routine.

Limited to US banking investors.

Low

Counterpoint

The purchase could be a routine portfolio rebalancing rather than a bullish signal.

Key entities

  • Gary Torgow

    Director of Huntington Bancshares

  • Huntington Bancshares Inc.

    Regional bank listed on NYSE under ticker HBAN

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HBANMedAI 8/10

Huntington Bancshares 3Q 2026: Revenue $2.79B, EPS $0.33— 10-Q Summary

Huntington Bancshares reported 3Q 2026 revenue of $2.79B, up 30.8% YoY, and net income of $721M, up 14.6% YoY. EPS was $0.33, down 19.5% YoY, due to acquisition-related expenses. Growth was driven by acquisitions, organic growth, and higher net interest income. Management highlighted progress in integrating recent acquisitions and investing in technology.

$SEBMed

Sweden’s SEB pauses buybacks as Barclays plans further capital returns ahead of Basel 3.1

SEB paused buybacks due to capital buffer pressure from model adjustments and loan growth, reporting a 17.1% CET1 ratio. Barclays announced a GBP 500M buyback, expecting Basel 3.1 to reduce its CET1 ratio but maintain distribution headroom. EU agreed lower capital requirements for qualifying securitisations. Huntington Bancshares saw diverging capital ratios due to interest-rate losses. BPI's provisions fell despite worsening problem-loan metrics.

$HBANMedAI 8/10

Huntington Bancshares Inc (HBAN) (Q3 2026) Earnings Call Highlights: Strong Fee Growth

Huntington Bancshares (HBAN) reported strong Q3 2026 results, with fee revenue up over 15% YoY and commercial loan growth driving a 1.1% increase in loan balances. The company expects 2027 EPS growth of over 20% and ROTCE of 17%-18%. However, it faces challenges like a competitive environment and slightly lowered fee revenue guidance for Q4. The bank repurchased $460 million in stock YTD and plans $1.8-$1.9 billion in buybacks for 2026-2027.

$HBANHighAI 8/10

Huntington Bancshares Inc (HBAN) (Q3 2026) Earnings Call Highlig

Huntington Bancshares (HBAN) reported Q3 2026 earnings with net interest income up 0.9% quarter-over-quarter and 37% year-over-year. Net interest margin increased 4 basis points to 3.25%. Non-interest expense remained flat, while value-added fee revenue rose over 15% year-over-year. Loans grew 1.1% period-end, and deposits increased 0.2%. The company expects 2027 EPS growth of over 20% and plans $1.8-$1.9 billion in share repurchases through 2027.

$HBANMed

Huntington (HBAN) Q3 2026 Earnings Call Transcript

Huntington (HBAN) reported strong Q3 2026 earnings, with C&I growth driven by national commercial strategy. The company expects 2027 EPS to grow over 20% from 2025, with ROTCE in the 17-18% range. They have completed $460 million in share repurchases year-to-date and plan to return substantial capital to shareholders. Huntington's operating model combines local and national commercial banking, with $191 billion in loans and $225 billion in deposits.

$HBANMed

What Huntington Bancshares (HBAN) Said on Its Q3 Earnings Call

Huntington Bancshares (HBAN) reported Q3 earnings with net interest income at $2.1B, up 0.9% sequentially. Net interest margin increased to 3.25%, with management expecting it to remain flat in Q4. Fee revenue grew 15% YoY, and noninterest expense was stable. The company repurchased $460M of common stock YTD and expects $1.8B-$1.9B in repurchases over 2023-2024. Net charge-offs were 31 basis points, with stable credit performance.